Platelet peripheral benzodiazepine receptors are decreased in Parkinson's disease
- Univ. of Pisa (Italy)
Peripheral benzodiazepine (BDZ) receptors are located in a variety of tissues, including platelets, in the nuclear and/or mitochondrial membranes. The authors studied the density of peripheral BDZ receptors in platelets of 10 de novo Parkinson's disease (PD) patients, 18 PD patients treated with a levodopa/carbidopa combination, and in 15 healthy subjects matched for sex and age. The binding assay was conducted using ({sup 3}H)PK 11195, a specific ligand for peripheral BDZ receptors. A significant decrease in the density of ({sup 3}H)PK 11195 binding sites has been observed in PD patients with respect to controls but not between de novo and treated PD patients. No correlation has been found between the decrease in density of ({sup 3}H)PK 11195 binding sites in platelets and either the duration or severity of PD. Peripheral BDZ receptors are implicated in the regulation of mitochondrial respiratory function. Thus, their decrease in PD might parallel the abnormalities in mitochondrial function recently found in this neurologic disease.
- OSTI ID:
- 5915649
- Journal Information:
- Life Sciences; (USA), Vol. 48:12; ISSN 0024-3205
- Country of Publication:
- United States
- Language:
- English
Similar Records
Aldosterone-reversible decrease in the density of renal peripheral benzodiazepine receptors in the rat after adrenalectomy
Platelet peripheral benzodiazepine receptors in repeated stress
Related Subjects
NERVOUS SYSTEM DISEASES
PATHOGENESIS
RECEPTORS
BIOLOGICAL LOCALIZATION
TRANQUILIZERS
BIOCHEMICAL REACTION KINETICS
BLOOD PLATELETS
MITOCHONDRIA
PATIENTS
TRACER TECHNIQUES
TRITIUM COMPOUNDS
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BODY FLUIDS
CELL CONSTITUENTS
CENTRAL NERVOUS SYSTEM AGENTS
DISEASES
DRUGS
HYDROGEN COMPOUNDS
ISOTOPE APPLICATIONS
KINETICS
MATERIALS
MEMBRANE PROTEINS
ORGANIC COMPOUNDS
ORGANOIDS
PROTEINS
PSYCHOTROPIC DRUGS
REACTION KINETICS
550901* - Pathology- Tracer Techniques